In addition, our findings that mTOR signalling-activity-related markers (both p-S6 and Rictor expression), as part of metabolic plasticity evaluation, help to predict prognosis subtype independently underline the importance of metabolic rewiring mechanisms in tumour cells and tissues, as well. This evidence concerns the gene RICTOR and neoplasm.